We take pride in our state-of-the-art active pharmaceutical manufacturing solution, specifically designed and built to standardize our cannabinoid-based therapy applications. Our technology suite includes GMP active extraction, intermediate API production, and API isolation, providing a full range of manufacturing capabilities.
Our bespoke manufacturing skids are designed to meet the highest global GMP requirements and regulations. By utilizing cryoethanol solutions and inline refinement technologies, we offer end-to-end pant-to-API solutions with maximized outputs and high-quality inputs. Our cost-considered technologies are engineered for high efficiencies, allowing for cost-effective scalability, thus enabling our customers to achieve their goals.
Our in-house QC operations, which accelerate research and development, create products that are highly homogenous with stable dosing and predictable effects. At our core, we believe that quality is paramount, and we strive to create products that meet the highest standards while delivering optimal patient outcomes.
The Leading Edge
Why Medical Cannabis?
Medical cannabis refers to the use of components as a therapy to manage certain ailment-specific conditions and their associated symptoms. These components of cannabis, specifically CBD and THC have shown to act on the endocannabinoid system within the body and so have been proven to have medicinal properties for certain diseases.
Pharmaceutical preparations of cannabis have been clinically tested and approved for use in the following indications:
- Lennox-Gastaut syndrome and Dravet Syndrome
- Spasticity associated with multiple sclerosis
- nausea and vomiting associated with chemotherapy
- Nausea and appetite loss due to chemotherapy, HIV or AIDS
At the heart of our company lies a core team of exceptionally talented and experienced professionals. We are a group of technically-skilled chemical and process pharmaceutical engineers, analytical chemists, regulatory pharmacists, production pharmacists, packaging/brand specialists, and GMP quality assurance experts who share a common vision of creating world-class medical cannabis API products.
Under the visionary leadership of Peter-William Nel, we have carved out a unique niche in the industry. We are hyper-focused on delivering high-quality API cannabinoids and alkaloids with specific dosage formats that meet the needs of patients worldwide. As a technology provider, our initial focus was on research and development, and model development. Today, we have leveraged our strengths to drive innovation in the cannabinoid and alkaloid manufacturing space.
We are driven by a relentless desire to push the boundaries of what is possible. We thrive on tackling the most challenging problems and delivering solutions that exceed expectations. Our commitment to quality and innovation is unmatched, and we are dedicated to creating products that truly make a difference in the lives of patients. Join us on our journey as we continue to break new ground in the world of medical cannabis.